These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24637801)

  • 1. Functional defects in NOD2 signaling in experimental and human Crohn disease.
    Corridoni D; Arseneau KO; Cominelli F
    Gut Microbes; 2014; 5(3):340-4. PubMed ID: 24637801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated NOD2 predisposes SAMP1/YitFc mice to chronic intestinal inflammation.
    Corridoni D; Kodani T; Rodriguez-Palacios A; Pizarro TT; Xin W; Nickerson KP; McDonald C; Ley KF; Abbott DW; Cominelli F
    Proc Natl Acad Sci U S A; 2013 Oct; 110(42):16999-7004. PubMed ID: 24082103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOD2 drives early IL-33-dependent expansion of group 2 innate lymphoid cells during Crohn's disease-like ileitis.
    De Salvo C; Buela KA; Creyns B; Corridoni D; Rana N; Wargo HL; Cominelli CL; Delaney PG; Rodriguez-Palacios A; Cominelli F; Vermeire S; Pizarro TT
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33444291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic deletion of the bacterial sensor NOD2 improves murine Crohn's disease-like ileitis independent of functional dysbiosis.
    Corridoni D; Rodriguez-Palacios A; Di Stefano G; Di Martino L; Antonopoulos DA; Chang EB; Arseneau KO; Pizarro TT; Cominelli F
    Mucosal Immunol; 2017 Jul; 10(4):971-982. PubMed ID: 27848951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in Crohn's disease by nucleotide oligomerization domain 2-dependent and -independent pathways.
    Brosbøl-Ravnborg A; Hvas CL; Agnholt J; Dahlerup JF; Vind I; Till A; Rosenstiel P; Höllsberg P
    Clin Exp Immunol; 2009 Mar; 155(3):487-95. PubMed ID: 19094116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and molecular mechanisms underlying NOD2 risk-associated polymorphisms in Crohn's disease.
    Strober W; Asano N; Fuss I; Kitani A; Watanabe T
    Immunol Rev; 2014 Jul; 260(1):249-60. PubMed ID: 24942694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MDP-Induced selective tolerance to TLR4 ligands: impairment in NOD2 mutant Crohn's disease patients.
    Cantó E; Moga E; Ricart E; Garcia-Bosch O; Garcia-Planella E; Juarez C; Vidal S
    Inflamm Bowel Dis; 2009 Nov; 15(11):1686-96. PubMed ID: 19572373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOD2 is dispensable for ATG16L1 deficiency-mediated resistance to urinary tract infection.
    Wang C; Yuan X; Ma E; Mendonsa GR; Plantinga TS; Kiemeney LA; Vermeulen SH; Mysorekar IU
    Autophagy; 2014 Feb; 10(2):331-8. PubMed ID: 24384785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NOD2 Influences Trajectories of Intestinal Microbiota Recovery After Antibiotic Perturbation.
    Moltzau Anderson J; Lipinski S; Sommer F; Pan WH; Boulard O; Rehman A; Falk-Paulsen M; Stengel ST; Aden K; Häsler R; Bharti R; Künzel S; Baines JF; Chamaillard M; Rosenstiel P
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):365-389. PubMed ID: 32289499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How NOD2 mutations predispose to Crohn's disease?
    Vignal C; Singer E; Peyrin-Biroulet L; Desreumaux P; Chamaillard M
    Microbes Infect; 2007 Apr; 9(5):658-63. PubMed ID: 17379562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innate immunity in Crohn's disease: the reverse side of the medal.
    Dessein R; Chamaillard M; Danese S
    J Clin Gastroenterol; 2008 Sep; 42 Suppl 3 Pt 1():S144-7. PubMed ID: 18806708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis.
    Pizarro TT; Pastorelli L; Bamias G; Garg RR; Reuter BK; Mercado JR; Chieppa M; Arseneau KO; Ley K; Cominelli F
    Inflamm Bowel Dis; 2011 Dec; 17(12):2566-84. PubMed ID: 21557393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of NOD2 on the microbiota in Crohn's disease.
    Lauro ML; Burch JM; Grimes CL
    Curr Opin Biotechnol; 2016 Aug; 40():97-102. PubMed ID: 27035071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complex interplay of NOD-like receptors and the autophagy machinery in the pathophysiology of Crohn disease.
    Billmann-Born S; Lipinski S; Böck J; Till A; Rosenstiel P; Schreiber S
    Eur J Cell Biol; 2011; 90(6-7):593-602. PubMed ID: 21146253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The primary defect in experimental ileitis originates from a nonhematopoietic source.
    Olson TS; Reuter BK; Scott KG; Morris MA; Wang XM; Hancock LN; Burcin TL; Cohn SM; Ernst PB; Cominelli F; Meddings JB; Ley K; Pizarro TT
    J Exp Med; 2006 Mar; 203(3):541-52. PubMed ID: 16505137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide-binding oligomerization domain 2 signaling promotes hyperresponsive macrophages and colitis in IL-10-deficient mice.
    Jamontt J; Petit S; Clark N; Parkinson SJ; Smith P
    J Immunol; 2013 Mar; 190(6):2948-58. PubMed ID: 23396949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muramyl dipeptide activation of nucleotide-binding oligomerization domain 2 protects mice from experimental colitis.
    Watanabe T; Asano N; Murray PJ; Ozato K; Tailor P; Fuss IJ; Kitani A; Strober W
    J Clin Invest; 2008 Feb; 118(2):545-59. PubMed ID: 18188453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nod1 and Nod2 in innate immunity and human inflammatory disorders.
    Le Bourhis L; Benko S; Girardin SE
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1479-84. PubMed ID: 18031249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The protein Nod2: an innate receptor more complex than previously assumed.
    Lecat A; Piette J; Legrand-Poels S
    Biochem Pharmacol; 2010 Dec; 80(12):2021-31. PubMed ID: 20643110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of estrogen-mediated immunoprotection underlies female gender bias in experimental Crohn's-like ileitis.
    Goodman WA; Garg RR; Reuter BK; Mattioli B; Rissman EF; Pizarro TT
    Mucosal Immunol; 2014 Sep; 7(5):1255-65. PubMed ID: 24621993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.